Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis

Creative Commons License

Terzioglu E., Bisgin A., Sanlioglu A. D., Ulker M., Yazisiz V., Tuzuner S., ...Daha Fazla

RHEUMATOLOGY, cilt.46, sa.5, ss.783-789, 2007 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 46 Sayı: 5
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1093/rheumatology/kel448
  • Dergi Adı: RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.783-789
  • Çukurova Üniversitesi Adresli: Hayır

Özet

Objectives. Rheumatoid arthritis (RA) is characterized by the chronic inflammation of the synovial joints resulting from the hyperplasia of synovial cells and the infiltration of lymphocytes, macrophages and plasma cells. Currently, the aetiology of RA is not known, and new treatment modalities are needed to prevent the disease progression. Apoptosis induction of synovial cells through the use of death ligands has been explored as a treatment modality for RA. Thus, the primary objective of this study was the testing of the efficacy of adenovirus delivery of human TRAIL (Ad5hTRAIL) for the treatment of patients with RA.